AUGMENTIN
-
India starts making key API clavulanic acid
"As of now we are largely dependent on China. With the initiative of the production-linked incentive scheme companies, we will see production of clavulanic acid and Pencillin G by the end of this year. Kinvan is in advanced stages and large scale fermentation is expected by the end of this year. It's a step in the right direction," a person in the know said.
-
Respiratory drug Foracort No. 1 in sales
-
Indian pharma market grows over 9 per cent in December
-
Virals beaten back? Diabetic meds’ sales rebound in April
-
Augmentin tops sales in February on flu, Covid
-
Is Sitagliptin opportunity making Indian oral antidiabetic drug market competitive?
-
Indian pharma market grew 14.1% in July, AIOCD report
-
Pharma sales rise in June after a 2-month slump
Advertisement
Advertisement